Signaling Specific News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Signaling Specific. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Signaling Specific Today - Breaking & Trending Today

Aelis Farma Announces Completion of Patient Randomization for Phase 2B Study with Aef0117 for the Treatment of Cannabis Addiction

Published: January 9, 2024

Aelis Farma announced to have reached a key milestone by successfully completing the recruitment of 333 patients suffering from cannabis addiction in its Phase 2b clinical study with AEF0117. AEF0117...

Source: marketscreener.com

Related Topics:

Aelis Farma Announces Positive Results of Non-clinical Studies Required by Regulatory Agencies to En

Published: November 8, 2023

Positive results of in vivo toxicology studies in which AEF0117 shows a favorable therapeutic index >13,000 time the active dose:Chronic oral toxicity studies (6 months in rats and 9 months in dog) allowing for unrestricted chronic treatment in humans.Reproductive toxicology studies showing that AEF0117 does not mod...

Source: pharmiweb.com

Related Topics:

New York United States Vincenzo Piazza Neurocentre Magendie Arthur Rouill Daelis Farma Novo Nordisk Frances Levin Columbia University Regulatory News Signaling Specific Pier Vincenzo Piazza Frances Levin Columbia University Down Syndrome Universal Registration Document Des March Nature Medicine Can Protect Cannabis Intoxication

Results of Aelis Farma Combined General Meeting of May 24, 2023

Published: May 25, 2023

Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 Ticker: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, announces that all the

Source: finanznachrichten.de

Related Topics:

United States Gewinn Nur Arthur Rouill Daelis Farma Vincenzo Piazza Magendie Neurocenter Anders Gersel Pedersen Regulatory News Combined General Meeting Chief Executive Officer Lafaurie De Monbadon Signaling Specific Pier Vincenzo Piazza Down Syndrome Euronext Paris Universal Registration Document Des March

Aelis Farma: Combined General Meeting of May 24, 2023: Availability of Preparatory Documents and Participation and Voting Procedures

Published: May 2, 2023

Aelis Farma (ISIN: FR0014007ZB4 Ticker: AELIS, PEA-PME eligible) (Paris: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, informs

Source: finanznachrichten.de

Related Topics:

United States France General Vincenzo Piazza Magendie Neurocenter Daelis Farma Arthur Rouill Combined General Meeting Lafaurie De Mondabon General Meeting Investors General Commercial Code Signaling Specific Pier Vincenzo Piazza Down Syndrome Euronext Paris Universal Registration Document Des March

Aelis Farma: Publication of the 2022 Universal Registration Document

Published: April 27, 2023

Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 Ticker: AELIS) (Paris: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, announces

Source: finanznachrichten.de

Related Topics:

France General United States Daelis Farma Arthur Rouill Vincenzo Piazza Magendie Neurocenter French Financial Markets Authority Autorit Regulatory News Registration Document French Financial Markets Authority Des March Universal Registration Document Investors Documentation General Meeting Signaling Specific Pier Vincenzo Piazza Down Syndrome Euronext Paris

Page 2 Page 3 Page 4 Page 5